Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
59.58
+0.31 (0.52%)
Oct 15, 2025, 4:00 PM EDT - Market closed
Bio-Techne Revenue
In the fiscal year ending June 30, 2025, Bio-Techne had annual revenue of $1.22B with 5.23% growth. Bio-Techne had revenue of $316.96M in the quarter ending June 30, 2025, with 3.55% growth.
Revenue (ttm)
$1.22B
Revenue Growth
+5.23%
P/S Ratio
7.70
Revenue / Employee
$393,431
Employees
3,100
Market Cap
9.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 1.22B | 60.58M | 5.23% |
Jun 30, 2024 | 1.16B | 22.36M | 1.97% |
Jun 30, 2023 | 1.14B | 31.10M | 2.81% |
Jun 30, 2022 | 1.11B | 174.57M | 18.75% |
Jun 30, 2021 | 931.03M | 192.34M | 26.04% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TECH News
- 1 day ago - Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents - Business Wire
- 1 day ago - Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results - PRNewsWire
- 7 days ago - Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 - PRNewsWire
- 20 days ago - Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications - PRNewsWire
- 22 days ago - Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report - PRNewsWire
- 5 weeks ago - Bio-Techne Corporation (TECH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Bio-Techne Corporation (TECH) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California - PRNewsWire